"10.1371_journal.pone.0032659","plos one","2012-03-12T00:00:00Z","Beatriz Trenor; Karen Cardona; Juan F Gomez; Sridharan Rajamani; Jose M Ferrero; Luiz Belardinelli; Javier Saiz","Instituto de Investigación Interuniversitario en Bioingeniería y Tecnología Orientada al Ser Humano, Universitat Politècnica de València, Valencia, Spain; Department of Biology, Gilead Sciences, Palo Alto, California, United States of America","Conceived and designed the experiments: BT. Performed the experiments: KC JFG BT. Analyzed the data: KC JFG BT LB SR JS JMF. Wrote the paper: BT SR LB.","The authors have read the journals policy and have the following conflicts: Dr. Belardinelli and Dr. Rajamani are employees of Gilead Sciences, the US company that markets Ranexa, and own stock and stock options. They are reimbursed for travel expenses to lecture on this subject. They have numerous patents related to late INA inhibitors, a list of which can be provided on request. This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials.","2012","03","Beatriz Trenor","BT",7,TRUE,1,3,7,3,TRUE,TRUE,FALSE,0,NA,FALSE
